Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Images are illustrative
"I hope it doesn't get to that," Brooks said, adding the medication "just makes life easier." 3 million Canadians use GLP-1 drugs
ScienceDirect , Cell Metabolism , vol
INDICATIONS AND USAGE LINZESS (linaclotide) is indicated for the treatment of: irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older chronic idiopathic constipation (CIC) in adults functional constipation (FC) in pediatric patients 6 years of age and older IMPORTANT SAFETY INFORMATION WARNING: RISK OF SERIOUS DEHYDRATION IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE LINZESS is contraindicated in patients less than 2 years of age
10.1016/j.arcmed.2014.11.020 139 WanT
US$ 29.18
US$ 26.07
US$ 23.37
US$ 21.01
US$ 21.05
US$ 24.23
